Cogstate Limited (ASX:CGS)
2.480
+0.270 (12.22%)
At close: Dec 19, 2025
Cogstate Market Cap
Cogstate has a market cap or net worth of 425.63 million as of December 19, 2025. Its market cap has increased by 116.65% in one year.
Market Cap
425.63M
Enterprise Value
372.10M
Revenue
80.98M
Ranking
n/a
PE Ratio
27.89
Stock Price
2.48
Market Cap Chart
Since February 16, 2004, Cogstate's market cap has increased from 4.34M to 425.63M, an increase of 9,701.18%. That is a compound annual growth rate of 23.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 425.63M | 137.74% |
| Dec 31, 2024 | 179.03M | -27.11% |
| Dec 29, 2023 | 245.63M | -27.75% |
| Dec 30, 2022 | 339.98M | -18.95% |
| Dec 31, 2021 | 419.47M | 124.00% |
| Dec 31, 2020 | 187.26M | 185.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.46B |
| Pro Medicus | 22.71B |
| Cochlear | 16.85B |
| Sonic Healthcare | 11.16B |
| Ramsay Health Care | 7.96B |
| Ansell | 5.06B |
| Telix Pharmaceuticals | 4.01B |
| Mesoblast | 3.73B |